Genetic Markers And Outcome Of Cll Patients In Combined Time-Limited Treatment With Anti-Cd20 Antibody + Ibrutinib, Idelalisib Or Venetoclax In The Gcllsg Cll2-Bag, -Bcg, -Big And -Bio Phase-Ii Trials
Ibrutinib;Idelalisib;Venetoclax
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Genetic Markers And Outcome Of Cll Patients In Combined Time-Limited Treatment With Anti-Cd20 Antibody + Ibrutinib, Idelalisib Or Venetoclax In The Gcllsg Cll2-Bag, -Bcg, -Big And -Bio Phase-Ii Trials ### Output: Ibrutinib;Idelalisib;Venetoclax